3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Neoplasm Metastasis
2
von Hippel-Lindau Disease
1
Unilateral Breast Neoplasms
1
Triple Negative Breast Neoplasms
1
Thymus Neoplasms
1
Sarcoma, Kaposi
1
Sarcoma
1
Recurrence
1
Neuroendocrine Tumors
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Meningioma
1
Liposarcoma
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Hamartoma Syndrome, Multiple
1
Glioma
1
Glioblastoma
1
Endometrial Neoplasms
1
Diffuse Intrinsic Pontine Glioma
1
Brain Neoplasms
1
Bone Neoplasms
1
Autistic Disorder
1
Astrocytoma
1
Advanced Lung Neuroendocrine Tumor
1
Interventions
Imatinib Mesylate
4
Sunitinib
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
trastuzumab deruxtecan
1
ripretinib
1
pemigatinib
1
Surgical Instruments
1
Rogaratinib
1
Nivolumab
1
Midazolam
1
Ipilimumab
1
IDRX-42
1
CTLA-4 Antigen
1
Biopsy
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Gastrointestinal Stromal Tumors
×
Everolimus
×
30 days
×
Clear all
No trials found.